-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Raised to $13 at H.C. Wainwright
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Raised to $12 at H.C. Wainwright
-
-
-
-
-
-
-
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
-
-
-
-
-
-
-
Cantor Fitzgerald reports key Takeaways from call with RadioMedia CEO
-
-
-
-
-
-
-
Scotiabank Starts Perspective Therapeutics Inc (CATX) at Sector Outperform
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Perspective Therapeutics Inc (CATX)
-
-
-
-
-
-
-
RBC's biotech survey shows investors more bearish vs. last time
-
446,788 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

